scholarly journals Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more

2018 ◽  
Vol 143 (2) ◽  
pp. 333-342 ◽  
Author(s):  
Annarosa Del Mistro ◽  
Rachael Adcock ◽  
Francesca Carozzi ◽  
Anna Gillio-Tos ◽  
Laura De Marco ◽  
...  
2006 ◽  
Vol 85 (4) ◽  
pp. 444-450 ◽  
Author(s):  
André Luis Ferreira Santos ◽  
Sophie Françoise Mauricette Derchain ◽  
Luis Otávio Sarian ◽  
Marcos Roberto Martins ◽  
Sirlei Siani Morais ◽  
...  

2018 ◽  
Author(s):  
Peng Xue ◽  
Li-Li Gao ◽  
Jian Yin ◽  
Li-Li Han ◽  
Jing Zhao ◽  
...  

ABSTRACTThis study is to evaluate performances and genotyping capabilities of four human papilloma virus (HR-HPV) tests based on real-time polymerase chain reaction (PCR) technology platforms compared with the cobas test. Discordant results were further analyzed using INNO-LiPA HPV genotyping test, the gold standard laboratory test to determine presence and type of HPV infection. Over 200 samples from Hospital patients were collected and analyzed using five HR-HPV tests. Women with positive test results were referred directly to colposcopy. If a positive result was returned, biopsies were administered for pathological classification. Clinical performances and genotyping capabilities between the four HR-HPV and cobas tests were compared and contrasted. High levels of agreement were observed, though all HR-HPV tests presented discrepancies compared with the cobas test. Cervical intraepithelial neoplasia Grade 2 or higher lesions (CIN2+) was set as the threshold, and all five tests performed with equally high sensitivity. Lower levels of specificity were observed across all five tests. Results suggest the four HR-HPV tests analyzed are as effective as the cobas test in genotyping capacities and diagnosing CIN. Therefore, these test kits should be used for HPV screening, especially in developing nations because they are cost effective and reliable. Minor discrepancies between tests are generally unavoidable though this may add complexity to the clinical decision-making process. As such, we recommend that efforts be made to standardize HPV genotyping tests as well as to optimize clinical sensitivity and specificity. Focusing on these issues will drive the development of HPV detection techniques, therefore save lives.


2012 ◽  
Vol 125 ◽  
pp. S50-S51
Author(s):  
K. Harris ◽  
T. Kiet ◽  
G. Sawaya ◽  
S. Wilczynski ◽  
K. Smith-McCune ◽  
...  

2003 ◽  
Vol 88 (3) ◽  
pp. 345-350 ◽  
Author(s):  
Benny Almog ◽  
Ronni Gamzu ◽  
Michael J Kuperminc ◽  
Ishai Levin ◽  
Ofer Fainaru ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document